Teva Pharmaceuticals USA Inc., Boehringer Ingelheim Pharmaceuticals, Inc., and other pharmaceutical companies are defendants in multidistrict litigation where it is alleged they engaged in a pay-for-delay scheme over the stroke drug Aggrenox.
Menu